Evidence map›Paper›PMID 25627681›Full record

ArticleThe Journal of biological chemistry2015

Roles of the NH2-terminal domains of cardiac ryanodine receptor in Ca2+ release activation and termination.

Yingjie Liu, Bo Sun, Zhichao Xiao, Ruiwu Wang, Wenting Guo, Joe Z Zhang, Tao Mi, Yundi Wang, Peter P Jones, Filip Van Petegem and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Structure and Function of IPCold Spring Harbor perspectives in biology · 2019
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Yingjie LiuFrom the Libin Cardiovascular Institute of Alberta, Departments of Physiology and Pharmacology and Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta T2N 4N1, Canada.
Bo SunFrom the Libin Cardiovascular Institute of Alberta, Departments of Physiology and Pharmacology and Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta T2N 4N1, Canada.
Zhichao XiaoFrom the Libin Cardiovascular Institute of Alberta, Departments of Physiology and Pharmacology and Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta T2N 4N1, Canada.
Ruiwu WangFrom the Libin Cardiovascular Institute of Alberta, Departments of Physiology and Pharmacology and Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta T2N 4N1, Canada.
Wenting GuoFrom the Libin Cardiovascular Institute of Alberta, Departments of Physiology and Pharmacology and Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta T2N 4N1, Canada.
Joe Z ZhangDepartment of Physiology and HeartOtago, University of Otago, Dunedin 9054, New Zealand, and.
Tao MiFrom the Libin Cardiovascular Institute of Alberta, Departments of Physiology and Pharmacology and Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta T2N 4N1, Canada.
Yundi WangFrom the Libin Cardiovascular Institute of Alberta, Departments of Physiology and Pharmacology and Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta T2N 4N1, Canada.
Peter P JonesDepartment of Physiology and HeartOtago, University of Otago, Dunedin 9054, New Zealand, and.
Filip Van PetegemCardiovascular Research Group, Life Sciences Institute, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada.
S R Wayne ChenFrom the Libin Cardiovascular Institute of Alberta, Departments of Physiology and Pharmacology and Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta T2N 4N1, Canada, swchen@ucalgary.ca.
University of Calgary · CALibin Cardiovascular Institute of Alberta · CAUniversity of Otago · NZUniversity of British Columbia · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

The NH2-terminal region (residues 1-543) of the cardiac ryanodine receptor (RyR2) harbors a large number of mutations associated with cardiac arrhythmias and cardiomyopathies. Functional studies have revealed that the NH2-terminal region is involved in the activation and termination of Ca(2+) release. The three-dimensional structure of the NH2-terminal region has recently been solved. It is composed of three domains (A, B, and C). However, the roles of these individual domains in Ca(2+) release activation and termination are largely unknown. To understand the functional significance of each of these NH2-terminal domains, we systematically deleted these domains and assessed their impact on caffeine- or Ca(2+)-induced Ca(2+) release and store overload-induced Ca(2+) release (SOICR) in HEK293 cells. We found that all deletion mutants were capable of forming caffeine- and ryanodine-sensitive functional channels, indicating that the NH2-terminal region is not essential for channel gating. Ca(2+) release measurements revealed that deleting domain A markedly reduced the threshold for SOICR termination but had no effect on caffeine or Ca(2+) activation or the threshold for SOICR activation, whereas deleting domain B substantially enhanced caffeine and Ca(2+) activation and lowered the threshold for SOICR activation and termination. Conversely, deleting domain C suppressed caffeine activation, abolished Ca(2+) activation and SOICR, and diminished protein expression. These results suggest that domain A is involved in channel termination, domain B is involved in channel suppression, and domain C is critical for channel activation and expression. Our data shed new insights into the structure-function relationship of the NH2-terminal domains of RyR2 and the action of NH2-terminal disease mutations.

Indexed as

Blotting, WesternCaffeineCalciumHEK293 CellsHumansMyocardiumRyanodine Receptor Calcium Release ChannelCaffeineCalciumRyanodine Receptor Calcium Release ChannelCalcium ImagingCalcium Intracellular ReleaseCardiac MuscleRyanodine ReceptorSarcoplasmic Reticulum (SR)

Identifiers

PMID25627681
PMCPMC4367275
OpenAlexW2041304599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.